Tucker Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Tucker Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,749	Closed	-$88.6K	–	1800
2023 Q4	$88.6K	Buy	+3,749	New	+$66.8K	0.02%	239

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tucker Asset Management's CBAY Position: Q1 2024 in Review

Tucker Asset Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 3,749 shares — an estimated $88.6K sold.

Tucker Asset Management first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $88.6K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Tucker Asset Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Tucker Asset Management sold 3,749 Cymabay Therapeutics shares in Q1 2024, an estimated $88.6K.
Tucker Asset Management first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Tucker Asset Management's Cymabay Therapeutics position peaked at $88.6K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Tucker Asset Management's 13F filing for Q1 2024, filed 9 Aug 2024.